
|Articles|April 10, 2008
Abatacept approved by FDA for use in children
Bristol-Myers Squibb granted approval for arthritis biologic Orencia.
Advertisement
Children ages six years and older with moderately to severely active polyarticular juvenile idiopathic arthritis (JIA) may now get some relief from using abatacept (
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Addressing Depression Symptoms Can Significantly Improve Asthma Outcomes
2
President Trump Signs Sweeping, Unprecedented Federal PBM Reform
3
What the Newest Landmark PBM Reform Means for the Pharmacy Industry
4
Q&A: How Direct-to-Consumer Pharmacies Could Affect the Pharmacy Landscape
5























